These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current status of capecitabine in the treatment of colorectal cancer. Rothenberg ML Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635 [TBL] [Abstract][Full Text] [Related]
3. Treatment of colorectal cancer metastasis: the role of chemotherapy. Xiong HQ; Ajani JA Cancer Metastasis Rev; 2004; 23(1-2):145-63. PubMed ID: 15000155 [TBL] [Abstract][Full Text] [Related]
4. [New therapeutic options in chemotherapy of advanced colorectal cancer]. Reimer P; Rückle-Lanz H Med Klin (Munich); 2001 Oct; 96(10):593-8. PubMed ID: 11715331 [TBL] [Abstract][Full Text] [Related]
5. Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer. Cunningham D; James RD Eur J Cancer; 2001 May; 37(7):826-34. PubMed ID: 11313169 [TBL] [Abstract][Full Text] [Related]
6. New options for outpatient chemotherapy--the role of oral fluoropyrimidines. Cunningham D; Coleman R Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541 [TBL] [Abstract][Full Text] [Related]
7. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer. Moosmann N; Heinemann V Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070 [TBL] [Abstract][Full Text] [Related]
8. Advances in the treatment of metastatic colorectal cancer. Fishman AD; Wadler S Clin Colorectal Cancer; 2001 May; 1(1):20-35. PubMed ID: 12445376 [TBL] [Abstract][Full Text] [Related]
9. Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer. Fisher MD Clin Colorectal Cancer; 2001 Aug; 1(2):85-6. PubMed ID: 12445365 [No Abstract] [Full Text] [Related]
10. Oral versus intravenous fluoropyrimidines for colorectal cancer. Chionh F; Lau D; Yeung Y; Price T; Tebbutt N Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564 [TBL] [Abstract][Full Text] [Related]
11. The role of new agents in the treatment of colorectal cancer. Folprecht G; Köhne CH Oncology; 2004; 66(1):1-17. PubMed ID: 15031593 [TBL] [Abstract][Full Text] [Related]
12. [Controversy of treatment for advanced colorectal cancer--intermedisine]. Sato A; Shimada K; Taguchi S Gan To Kagaku Ryoho; 2003 Sep; 30(9):1260-9. PubMed ID: 14518404 [TBL] [Abstract][Full Text] [Related]
13. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting. Folprecht G; Köhne CH Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098 [TBL] [Abstract][Full Text] [Related]
14. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer. Hoff PM; Pazdur R; Benner SE; Canetta R Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235 [TBL] [Abstract][Full Text] [Related]
15. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?]. Carnaghi C; Zucali P; Garassino I Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298 [TBL] [Abstract][Full Text] [Related]